Harsh Parmar, MD

Harsh Parmar, MD, is an associate professor of medicine at Hackensack University Medical Center.

Articles by Harsh Parmar, MD

AJMC Q&A with Harsh Parmar, MD | Background image credit: ipopba - stock.adobe.com

The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD

May 17th 2025

Novel therapies for multiple myeloma (MM), including chimeric antigen receptor T-cell and bispecific antibodies, extend lives but raise concerns about treatment costs and adherence, and they haven't replaced stem cell transplantation, Harsh Parmar, MD, of Hackensack University Medical Center, explains.

Harsh Parmar, MD

Articles by Harsh Parmar, MD

The Role of Transplant in the Era of Novel MM Therapies: Harsh Parmar, MD

Latest Updated Articles

Trending on AJMC

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD